Biondo Investment Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History

Biondo Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$7.89 - $17.88 $2.06 Million - $4.67 Million	-261,205 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $96,815 - $165,490	-8,375 Reduced 3.11%	261,205 $4.25 Million
Q4 2021 Feb 08, 2022	BUY	$11.18 - $15.46 $23,478 - $32,466	2,100 Added 0.79%	269,580 $3.73 Million
Q3 2021 Nov 09, 2021	BUY	$14.21 - $17.65 $23,304 - $28,945	1,640 Added 0.62%	267,480 $3.84 Million
Q2 2021 Aug 03, 2021	BUY	$9.5 - $17.24 $2.53 Million - $4.58 Million	265,840 New	265,840 $4.2 Million

257

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.57B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Biondo Investment Advisors, LLC with notifications on news.